We are monitoring the impact of COVID-19 & Recession alarm on APAC Head & Neck Cancer Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

APAC Head & Neck Cancer Diagnostics Market Research Report – Segmented By Test Type, By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 40
Pages: 145

APAC Head & Neck Cancer Diagnostics Market Size (2022 to 2027)

The Head and Neck Cancer Diagnostics Market size in the Asia Pacific is estimated to grow with a CAGR of 13.62% from 2022 to 2027.

The Asia Pacific head and neck cancer diagnostics market is predicted to increase rapidly. The increasing number of cases of target diseases, the growing aging population, which has increased the prevalence of chronic diseases, the rising number of diagnostic procedures for head and neck cancer, better healthcare initiatives by governments and various private organizations, increased demand for diagnostic imaging, advancements in treatment techniques, and the inclusion of novel technologies in diagnostic equipment are some of the major trends driving the market. In addition, cancer awareness programs sponsored by governments and private organizations increase public awareness and allow for early cancer diagnosis.

Furthermore, technological developments in cancer screening procedures and the presence of pipeline medications like Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib Afatinib, Bevacizumab, and an increase in the number of R&D efforts to produce appropriate therapeutics, are projected to propel the market forward. In addition, other factors such as the large oncology research funding, unmet medical requirements, increased market competition, better regulatory framework, and increasing government aid contribute to the Asia Pacific head and neck cancer market's growth. In addition, the development of the head and neck cancer drugs/therapeutics market is expected to be driven by recent advancements in surgical procedures and non-surgical therapeutics such as immunotherapy and targeted therapy, which helps to improve quality of life by providing the most efficient care.

The low adoption rate of digital technology-based systems, conventional CT and MRI scanners, excise duty imposed on the sale of medical devices in mature markets, unfavorable government regulations regarding new research, high costs associated with treatment modes, and lack of awareness among the people are some of the market's restraining factors. In addition, the high price of treatment plans such as chemotherapy and immunotherapy and the side effects of ready-to-use treatment options are some of the significant factors limiting the growth of the Head And Neck Cancer Diagnostics Market. Temporary or permanent loss of normal voice, incorrect speech, and hearing loss are common adverse effects of head and neck surgery. In addition, after cancer surgery, patients usually find it difficult to chew or swallow, necessitating the insertion of a feeding tube into the stomach. This issue is hampering the expansion of the APAC Head and Neck Cancer Diagnostics Market.

This research report on the Asia-Pacific head and neck cancer diagnostics market has been segmented and sub-segmented into the following categories:

By Test Type: 

  • Dental Diagnostics
  • Endoscopy
  • Biopsy
  • Diagnostic Imaging

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The market in the Asia Pacific is also predicted to grow due to improved healthcare facilities and more public awareness. Due to the heavy consumption of alcoholic and tobacco products in this region, countries in Africa Asia-Pacific have the most significant prevalence of head and neck cancer cases. India and China are the largest markets for head and neck cancer diagnostics in Asia-Pacific. Due to the vast population base, increased incidence of head and neck cancer, and increased demand for head and neck cancer combination treatments, Asia-Pacific presents significant growth possibilities for key players operating in the head and neck cancer medications market. Betel quid chewing is the most popular tobacco chewing method in the Asia-Pacific region. Furthermore, rising healthcare expenditures and increased awareness about disease treatment and early detection propel the market's growth in this area.

KEY MARKET PLAYERS:

Companies playing a vital role in the APAC head and neck cancer diagnostics market profiled in the report are Philips Healthcare, GE Healthcare, Varian Siemens Healthcare, Medical Systems, Shimadzu Corporation, Velscope VX, Identafi, and AdDent Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test type               

                                5.1.1 Diagnostic imaging              

                                                5.1.1.1 PET/CT

                                                5.1.1.2 MRI

                                                5.1.1.3 X-ray

                                                5.1.1.4 Barium Swallow test

                                5.1.2 Biopsy       

                                                5.1.2.1 Incisional Biopsy

                                                5.1.2.2 Fine needle aspiration Biopsy

                                                5.1.2.3 HPV testing

                                5.1.3 Endoscopy              

                                                5.1.3.1 Pharyngoscopy

                                                5.1.3.2 Laryngoscopy

                                                5.1.3.3 Panendoscopy

                                5.1.4 Dental diagnostics

                                                5.1.4.1 Fluorescence Visualization

                                                5.1.4.2 Toluidine blue dye based method

                                                5.1.4.3 Acetic acid rinse method

                                                5.1.4.4 Brush biopsy

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 3M ESPE DENTAL SOLUTIONS                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 BIOMET 3I                   

                8.3 DENTSPLY INTERNATIONAL, INC                        

                8.4 HENRY SCHEIN, INC.               

                8.5 KERR CORPORATION                              

                8.6 IVOCLAR VIVADENT AG                         

                8.7 NOBEL BIOCARE                       

                8.8 PATTERSON COMPANIES, INC.                           

                8.9 ULTRADENT PRODUCTS                        

                8.10 ZIMMER DENTAL                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Head and Neck Cancer Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Head and Neck Cancer Diagnostics Market, By Test Type, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Diagnostic imaging Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Biopsy Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Endoscopy Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Dental diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Diagnostic Imaging Market, By Type, From 2022 - 2027 (USD Million)
  8. Asia-Pacific PET/CT Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific MRI Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific X-ray Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Barium Swallow test Market, By Region, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Biopsy Market, By Type, From 2022 - 2027 (USD Million)
  13. Asia-Pacific Incisional Biopsy Market, By Region, From 2022 - 2027 (USD Million)
  14. Asia-Pacific Fine needle aspiration Biopsy Market, By Region, From 2022 - 2027 (USD Million)
  15. Asia-Pacific HPV testing Market, By Region, From 2022 - 2027 (USD Million)
  16. Asia-Pacific Endoscopy Market, By Type, From 2022 - 2027 (USD Million)
  17. Asia-Pacific Pharyngoscopy Market, By Region, From 2022 - 2027 (USD Million)
  18. Asia-Pacific Laryngoscopy Market, By Region, From 2022 - 2027 (USD Million)
  19. Asia-Pacific Panendoscopy Market, By Region, From 2022 - 2027 (USD Million)
  20. Asia-Pacific Dental Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  21. Asia-Pacific Fluorescence Visualization Market, By Region, From 2022 - 2027 (USD Million)
  22. Asia-Pacific Toluidine blue dye based method Market, By Region, From 2022 - 2027 (USD Million)
  23. Asia-Pacific Acetic acid rinse method Market, By Region, From 2022 - 2027 (USD Million)
  24. Asia-Pacific Brush biopsy Market, By Region, From 2022 - 2027 (USD Million)
  25. China Head and Neck Cancer Diagnostics Market, By Test Type, From 2022 - 2027 (USD Million)
  26. India Head and Neck Cancer Diagnostics Market, By Test Type, From 2022 - 2027 (USD Million)
  27. Japan Head and Neck Cancer Diagnostics Market, By Test Type, From 2022 - 2027 (USD Million)
  28. South Korea Head and Neck Cancer Diagnostics Market, By Test Type, From 2022 - 2027 (USD Million)
  29. China Diagnostic Imaging Market, By Type, From 2022 - 2027 (USD Million)
  30. India Diagnostic Imaging Market, By Type, From 2022 - 2027 (USD Million)
  31. Japan Diagnostic Imaging Market, By Type, From 2022 - 2027 (USD Million)
  32. South Korea Diagnostic Imaging Market, By Type, From 2022 - 2027 (USD Million)
  33. China Biopsy Market, By Type, From 2022 - 2027 (USD Million)
  34. India Biopsy Market, By Type, From 2022 - 2027 (USD Million)
  35. Japan Biopsy Market, By Type, From 2022 - 2027 (USD Million)
  36. South Korea Biopsy Market, By Type, From 2022 - 2027 (USD Million)
  37. China Endoscopy Market, By Type, From 2022 - 2027 (USD Million)
  38. India Endoscopy Market, By Type, From 2022 - 2027 (USD Million)
  39. Japan Endoscopy Market, By Type, From 2022 - 2027 (USD Million)
  40. South Korea Endoscopy Market, By Type, From 2022 - 2027 (USD Million)
  41. China Dental Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  42. India Dental Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  43. Japan Dental Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  44. South Korea Dental Diagnostics Market, By Type, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample